Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies

From Hematologic Oncology Update · 57:54

Show by Dr. Neil Love

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:Introduction (0:00)Prologue: Saturday Night Fever (1:35)Baby Boomers' Guide to Mechanisms of Action (3:07)Second-Line Treatment (12:36)Complications Associated with Bispecific Antibodies (23:41)Case Presentations (25:52)New Bispecific T-Cell Engagers — Surovatamig (26:24)Other Novel Agents (50:05)CME information and select publications

More episodes of Hematologic Oncology Update

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.